| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |